Network pharmacology and molecular docking-based insights into the anti-melanoma potential of dalbergin

基于网络药理学和分子对接的达尔贝金抗黑色素瘤潜力研究

阅读:1

Abstract

Of all the skin malignancies, melanoma is the most invasive and challenging to treat. Melanoma patients have a poor prognosis and a high recurrence rate despite advancements in treatment. There is substantial evidence that plant-derived bioactives prevent and treat melanoma effectively. The naturally occurring bioactive compound dalbergin, found in certain species of the Dalbergia genus, such as Dalbergia sissoo, is a neoflavanoid that has been studied for its various biological and pharmacological properties, including its anticancer activity. Nevertheless, it is uncertain what mechanism underpins its anti-melanoma therapeutic benefits. This study aims to predict potential target proteins and suggest a possible molecular mechanism for dalbergin against melanoma using multiple systems biology databases and tools. Melanoma targets were identified through online databases and compared to proteins that were anticipated to be affected by dalbergin. Furthermore, pathways such as the MAPK signalling pathway, signal transduction, transcriptional control, and apoptosis regulation were identified using KEGG pathway analysis. Cytoscape was used to build a protein-protein interaction network, and six melanoma-associated hub targets, ERK1, ERK2, MAPK14, PTPN11, CDKN1B, and DUSP6, were identified through network analysis. Molecular docking studies demonstrated strong binding between dalbergin and the selected target proteins, with ERK1 showing the best binding (- 9.7 kcal/mol). Molecular dynamics simulations were performed for over 100 ns after molecular docking to confirm the structural stability of the dalbergin and ERK1/ERK2 complexes. This indicates the rationale for dalbergin as a potential bioactive in melanoma treatment. However, these predictions require confirmation through relevant in vitro and in vivo experimental studies to verify the precise mechanism, which is a limitation of the present work and a future scope. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40203-026-00604-9.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。